Corinna Horky

Corinna Horky

Auto-generated profile, based on publicly available information

Corinna Horky

Institute of Pharmaceutical Technology and Biopharmaceutics, University of Münster, Corrensstr. 48, D-48149 Münster, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
KVKatharina Völlmecke
Katharina Völlmecke
MKMaurice Kramer
Maurice Kramer
CHCorinna Horky
Corinna Horky
ODOliver Dückmann
Oliver Dückmann
DMDennis Mulac
Dennis Mulac
Dirk KucklingDirk Kuckling
Dirk Kuckling
Polydisulfide based nanoparticles can be degraded by glutathione (GSH) to deliver hydrophobic drugs.

29 August 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
MKMaurice Kramer
Maurice Kramer
MLMatthias van der Linde
Matthias van der Linde
LHLisa Hönscheid
Lisa Hönscheid
CHCorinna Horky
Corinna Horky
KVKatharina Völlmecke
Katharina Völlmecke
DLDr. Klaus Langer
Dr. Klaus Langer
To address the challenges associated with poor drug solubility and uncontrolled drug release in conventional dosage forms, a combination of polymer design and advanced drug delivery approaches has been employed. The development of pH-responsive nanoparticles for controlled and selective drug release represents a notable advance in adaptive nanomedicine. This study explores the design of a pH-responsive polymer, poly(1,4-phenyleneacetone dimethylene ketal) (PPADK). Additionally, the incorporation of light-responsive ortho-nitrobenzyl groups (o-NB-PPADK) enhanced the degradation upon exposure to light. Based on the polymer, nanoparticles were prepared using the solvent displacement method. The fluorescence dye Lumogen® Red was incorporated as a model substance. The nanoparticles were characterized by dynamic light scattering to determine their hydrodynamic diameter and size distribution, and the surface charge was analyzed. Atomic force microscopy was used to visualize the surface morphology. The nanoparticles remained stable under physiological pH conditions while exhibiting accelerated degradation and substance release in acidic environment, a property potentially exploitable for tumor targeting. Further enhanced degradation and correspondingly increased release was achieved by incorporating light-responsive elements in the polymer structure. The cytotoxicity of these newly designed nanoparticles was evaluated in cell culture using a breast cancer cell line. These results support the potential of o-NB-PPADK nanoparticles as a possible candidate for selective and effective cancer therapy, combining stimuli-responsive degradation mechanisms for improved therapeutic outcomes.

19 May 2026 in Next Nanotechnology
Verified
Journal Article
Open access
MKMaurice Kramer
Maurice Kramer
CHCorinna Horky
Corinna Horky
KVKatharina Völlmecke
Katharina Völlmecke
DMDennis Mulac-Hahnen
Dennis Mulac-Hahnen
FHFabian Christopher Herrmann
Fabian Christopher Herrmann
KLKlaus Langer
Klaus Langer

22 September 2026 in Polymer Chemistry
Verified
Journal Article
Open access
DHDavid Helle
David Helle
CHCorinna Horky
Corinna Horky
YHYvonne Hannappel
Yvonne Hannappel
DLDr. Klaus Langer
Dr. Klaus Langer
Dirk KucklingDirk Kuckling
Dirk Kuckling
Synthesis of polymer nanoparticles containing α-lipoic acid derivatives, which depolymerize in response to high concentrations of glutathione, as found in breast cancer cells, for use in drug delivery systems.